The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines
about
Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapyRoles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cellsA Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon CancerPLEKHM2 mutation leads to abnormal localization of lysosomes, impaired autophagy flux and associates with recessive dilated cardiomyopathy and left ventricular noncompactionThe pro-social neurohormone oxytocin reverses the actions of the stress hormone cortisol in human ovarian carcinoma cells in vitromiR-19b attenuates H2O2-induced apoptosis in rat H9C2 cardiomyocytes via targeting PTENBeside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets.Growth factor progranulin promotes tumorigenesis of cervical cancer via PI3K/Akt/mTOR signaling pathway.Analysis of the chemotherapeutic effects of a propadiene compound on malignant ovarian cancer cells.Akt isoform specific effects in ovarian cancer progression.Autophagy as an emerging therapy target for ovarian carcinomaGenome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities.Phosphatidylethanolamine-binding protein 4 promotes lung cancer cells proliferation and invasion via PI3K/Akt/mTOR axis.Resveratrol inhibits IL-6-induced ovarian cancer cell migration through epigenetic up-regulation of autophagy.Immunodeficiency-Associated Lymphoid Hyperplasia As a Cause of Intussusception in a Case of Activated PI3K-δ Syndrome.Autophagy inhibition promotes epithelial-mesenchymal transition through ROS/HO-1 pathway in ovarian cancer cells.Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancerNew Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian CancerPI3K/AKT/mTOR Pathway in Ovarian Cancer Treatment: Are We on the Right Track?miR-214 targets the PTEN-mediated PI3K/Akt signaling pathway and regulates cell proliferation and apoptosis in ovarian cancer.Effect of orthodontic force on the expression of PI3K, Akt, and P70S6 K in the human periodontal ligament during orthodontic loading.Ang1/Tie2 induces cell proliferation and migration in human papillary thyroid carcinoma via the PI3K/AKT pathway.Role of BMI1 in epithelial ovarian cancer: investigated via the CRISPR/Cas9 system and RNA sequencing.Adipokine RBP4 drives ovarian cancer cell migration.β-elemene induced anticancer effect in bladder cancer through upregulation of PTEN and suppression of AKT phosphorylationBu Shen Yang Xue Prescription Has Treating Effect on Endometrial Cancer through FSH/PI3K/AKT/Gankyrin/HIF-/cyclinD 1 Pathway in Ishikawa CellsAnticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
P2860
Q26769604-9A0ACB06-87F6-47FE-9238-99A8FDAB64C6Q28072650-9058219E-861B-46BD-8E1B-98DD64CACB63Q33776664-6065E030-DF36-4AB9-8F80-C994EF51256FQ36331577-04D9C524-A728-495C-96A1-3B600AE490FBQ36734187-FCEB39D4-6350-4FD5-8543-1E1AB692E5B4Q36998116-7E4DD5E6-7CAA-4772-B9E1-E1DE5A5B0F8FQ37406889-55D57D2B-B7F8-4735-9AD4-C39900121D1FQ37629030-79301D4F-3F30-4676-8DD8-C227FBC418D0Q37636771-50D590D3-75CB-49ED-8CDD-447D66F19816Q37688855-3E122310-FE6A-4797-9C5A-70663CC48842Q37696331-243CCE92-80A6-4050-8919-DD7C447FC44AQ37716509-1425A27C-909C-4827-B95F-C7864E7800D7Q38815411-1514EFC5-3D70-47F5-80E9-9AB6C0BC568CQ39243827-28D44448-D747-4A81-B426-AB6EAD5ADD0AQ40216172-9DD72EC2-17F6-4AA5-9D30-BD727768906BQ41632256-AA3B0211-5366-4B77-B82D-1A0B475FAF63Q41912578-90E121DC-8438-496C-9DB4-53CA8B180EB4Q42144129-DB5EB64C-8DD7-47E2-86B8-5AAF17023BCBQ43300329-0C83C51D-DF1D-4D73-8060-ADC897C07236Q47430029-46F82369-FA0F-462C-AB55-35482060ECB2Q47889942-F3BC817E-EB92-4846-91D8-8D28D3B07181Q49200404-3FBE669F-9754-4C20-B013-164C2EBD28D7Q52431796-41B590D5-71A0-4D91-B530-E5854EE1434DQ52593398-5272171E-41D6-4E15-AC64-6BAB6C3047BAQ58573344-4F13E82B-5066-4072-90D6-F4424C9ACCA4Q58578174-F4646805-F97A-411E-B1FE-468E15B3CE4FQ58775646-8A9EDBF4-2256-4F06-8D0E-04455E633F77
P2860
The PI3K/AKT/mTOR pathway is a potential predictor of distinct invasive and migratory capacities in human ovarian cancer cell lines
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The PI3K/AKT/mTOR pathway is a ...... uman ovarian cancer cell lines
@ast
The PI3K/AKT/mTOR pathway is a ...... uman ovarian cancer cell lines
@en
type
label
The PI3K/AKT/mTOR pathway is a ...... uman ovarian cancer cell lines
@ast
The PI3K/AKT/mTOR pathway is a ...... uman ovarian cancer cell lines
@en
prefLabel
The PI3K/AKT/mTOR pathway is a ...... uman ovarian cancer cell lines
@ast
The PI3K/AKT/mTOR pathway is a ...... uman ovarian cancer cell lines
@en
P2093
P2860
P356
P1433
P1476
The PI3K/AKT/mTOR pathway is a ...... uman ovarian cancer cell lines
@en
P2093
Dongyan Cao
Huimin Bai
Jiaxin Yang
P2860
P304
25520-25532
P356
10.18632/ONCOTARGET.4550
P407
P577
2015-07-14T00:00:00Z